MFIC.ob 2.20 with 10 million shares outstanding. With the CEO, Pfizer and a private investor now controlling almost 30% of MFIC's shares, that only leaves a very small amount of 7 million shares in the float. I am expecting record Q4 earnings to be reported shortly on the heels of its preannounced largest quarterly revenue figure. This news item and thin float could lead to an explosive upmove for the stock price. With the stock price above 2 the CEO is also seeking a national listing for the stock. IMO, MFIC is the most appealing profitable microcap in the nanotechnology landscape at this time.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.